• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Pineapple Financial And 2 Other Stocks Under $5 Insiders Are Buying

    7/19/24 2:01:32 PM ET
    $CYAN
    $PAPL
    $RVP
    Medicinal Chemicals and Botanical Products
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $CYAN alert in real time by email

    The Dow Jones index closed lower by more than 500 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

    Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

    Retractable Technologies

    • The Trade: Retractable Technologies, Inc. (NYSE:RVP) President and CEO Thomas J Shaw bought a total of 12,710 shares at an average price of $1.13. To acquire these shares, it cost around $14,352.
    • What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales results.
    • What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.

    Pineapple Financial

    • The Trade: Pineapple Financial Inc. (NYSE:PAPL) Director, CEO Shubha Dasgupta acquired a total of 2,000 shares at an average price of $0.97. To acquire these shares, it cost around $1,938.
    • What's Happening: On July 16, Pineapple Financial posted a third-quarter loss of 12 cents per share.
    • What Pineapple Financial Does: Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers.

    Cyanotech

    • The Trade: Cyanotech Corporation (NASDAQ:CYAN) Director Michael A / Davis acquired a total of 10,000 shares at an average price of $0.58. The insider spent around $5,800 to buy those shares.
    • What's Happening: On June 26, Cyanotech reported net sales of $23,071,000 for fiscal 2024 compared to $23,178,000 in fiscal 2023.
    • What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.

    Read Next:

    • Netflix To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Friday
    Get the next $CYAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CYAN
    $PAPL
    $RVP

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $CYAN
    $PAPL
    $RVP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Injective Foundation claimed ownership of 9,615,385 shares (SEC Form 3)

    3 - Pineapple Financial Inc. (0001938109) (Issuer)

    1/5/26 4:05:50 PM ET
    $PAPL
    Finance: Consumer Services
    Finance

    PRESIDENT AND CEO Shaw Thomas J bought $4,424 worth of shares (5,731 units at $0.77), increasing direct ownership by 0.04% to 15,831,222 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/17/25 11:29:38 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $81 worth of shares (100 units at $0.81), increasing direct ownership by 0.00% to 15,825,491 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/13/25 1:29:23 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $CYAN
    $PAPL
    $RVP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pineapple Financial Completes $2 Million INJ Purchase

    Acquires 560,647 INJ at average price of $3.567 per token as part of ongoing digital asset treasury strategy; $20.79 million in capital reserves available for future purchasesToronto, Ontario--(Newsfile Corp. - February 19, 2026) - Pineapple Financial Inc. (NYSE:PAPL) ("Pineapple" or the "Company") today announced that it has completed a $2 million open-market purchase of Injective (INJ) tokens. The acquisition of 560,647 INJ at a weighted average purchase price of $3.567 per token represents the latest milestone in the Company's ongoing digital asset treasury strategy.This purchase further strengthens Pineapple's position as a leading publicly traded company with a dedicated digital asset t

    2/19/26 8:30:00 AM ET
    $PAPL
    Finance: Consumer Services
    Finance

    Pineapple Financial to Participate in Upcoming February Investor Conferences

    Toronto, Ontario--(Newsfile Corp. - February 3, 2026) - Pineapple Financial Inc. (NYSE:PAPL) ("Pineapple" or "the Company"), a leading fintech platform, today announced that members of its leadership team and Board of Directors will participate in two upcoming investor conferences in February 2026.On Thursday, February 5, 2026, Shubha Dasgupta, CEO, Co-Founder & Director of Pineapple Financial, will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference. Noble Capital Markets Emerging Growth Virtual Equity ConferenceDate: Thursday, February 5, 2026Time: 9:30 a.m. ETPresenter: Shubha Dasgupta, CEO, Co-Founder & DirectorMore information: https://nobleconference.com/virt

    2/3/26 8:30:00 AM ET
    $PAPL
    Finance: Consumer Services
    Finance

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2025 through December 31, 2025. The dividends will be paid on January 20, 2026 to shareholders of record as of the close of business on January 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and

    12/30/25 4:14:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $CYAN
    $PAPL
    $RVP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT AND CEO Shaw Thomas J bought $4,424 worth of shares (5,731 units at $0.77), increasing direct ownership by 0.04% to 15,831,222 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/17/25 11:29:38 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $81 worth of shares (100 units at $0.81), increasing direct ownership by 0.00% to 15,825,491 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/13/25 1:29:23 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    PRESIDENT AND CEO Shaw Thomas J bought $6,195 worth of shares (7,500 units at $0.83), increasing direct ownership by 0.05% to 15,825,391 units (SEC Form 4)

    4 - RETRACTABLE TECHNOLOGIES INC (0000946563) (Issuer)

    11/6/25 10:53:09 AM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    $CYAN
    $PAPL
    $RVP
    SEC Filings

    View All

    SEC Form 15-12G filed by Cyanotech Corporation

    15-12G - CYANOTECH CORP (0000768408) (Filer)

    2/13/26 2:42:59 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13E3/A filed by Cyanotech Corporation

    SC 13E3/A - CYANOTECH CORP (0000768408) (Subject)

    2/13/26 2:09:31 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Pineapple Financial Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K - Pineapple Financial Inc. (0001938109) (Filer)

    2/10/26 4:56:17 PM ET
    $PAPL
    Finance: Consumer Services
    Finance

    $CYAN
    $PAPL
    $RVP
    Leadership Updates

    Live Leadership Updates

    View All

    Pineapple Financial Appoints Anthony Georgiades to Board of Directors and Special Advisory Committee

    Board Appointment Adds Digital Asset, Web3, and Institutional Investment Expertise to Treasury OversightToronto, Ontario--(Newsfile Corp. - December 29, 2025) - Pineapple Financial Inc. (NYSE:PAPL) ("Pineapple" or "the Company"), a leading fintech platform, today announced the appointment of Anthony Georgiades, General Partner at Innovating Capital, to its Board of Directors. Mr. Georgiades will also serve on Pineapple's newly formed Special Advisory Committee, which will oversee the Company's digital asset treasury strategy focused on accumulating Injective ($INJ) tokens.As a member of the Special Advisory Committee, Mr. Georgiades will work closely with management to guide governance, risk

    12/29/25 5:00:00 PM ET
    $PAPL
    Finance: Consumer Services
    Finance

    Pineapple Financial Establishes Digital Asset Treasury Advisory Board and Appoints Three Members from Injective Foundation

    Toronto, Ontario--(Newsfile Corp. - November 20, 2025) - Pineapple Financial Inc. (NYSE:PAPL) ("Pineapple" or "the Company"), a leading fintech platform, today announced the formation of a Digital Asset Treasury (DAT) Advisory Board as the Company advances its strategy of becoming the largest holder and staker of Injective ($INJ) and the premier on-chain mortgage finance platform in the world. The Advisory Board will initially include three members appointed from the Injective Foundation: Eric Chen, CEO and Co-Founder, Mirza Uddin, Head of Business, and Cooper Emmons, Institutional Lead. Each new member of the Advisory Board brings deep expertise in blockchain technology and decentralized fi

    11/20/25 9:00:00 AM ET
    $PAPL
    Finance: Consumer Services
    Finance

    Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment

    Cyanotech Corporation (Nasdaq Capital Market: CYAN), the world innovation leader in the cultivation and manufacture of microalgae for health and nutrition, including BioAstin® Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica®, today announces the appointment of Collette Kakuk as Chief Strategic and Commercial Officer. Ms. Kakuk brings an impressive background in business development, strategy, and marketing to add significant value to Cyanotech's growing stable of products. Her industry experience, combined with a passionate drive for sustainable and authentic product sourcing, makes her an ideal addition to Cyanotech's executive team. Recognizing growing global interest in microalgae

    8/1/23 8:00:00 AM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $CYAN
    $PAPL
    $RVP
    Financials

    Live finance-specific insights

    View All

    Pineapple Financial Completes $2 Million INJ Purchase

    Acquires 560,647 INJ at average price of $3.567 per token as part of ongoing digital asset treasury strategy; $20.79 million in capital reserves available for future purchasesToronto, Ontario--(Newsfile Corp. - February 19, 2026) - Pineapple Financial Inc. (NYSE:PAPL) ("Pineapple" or the "Company") today announced that it has completed a $2 million open-market purchase of Injective (INJ) tokens. The acquisition of 560,647 INJ at a weighted average purchase price of $3.567 per token represents the latest milestone in the Company's ongoing digital asset treasury strategy.This purchase further strengthens Pineapple's position as a leading publicly traded company with a dedicated digital asset t

    2/19/26 8:30:00 AM ET
    $PAPL
    Finance: Consumer Services
    Finance

    Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

    Retractable Technologies, Inc. ("Retractable") (NYSE:RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning October 1, 2025 through December 31, 2025. The dividends will be paid on January 20, 2026 to shareholders of record as of the close of business on January 10, 2026. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and

    12/30/25 4:14:00 PM ET
    $RVP
    Medical/Dental Instruments
    Health Care

    Pineapple Financial Reports Fiscal Year End 2025 Financial Results

    Reports FY 2025 revenue of $3.0 million, up 10% from $2.7 million in 2024Pineapple to host a call to discuss its results Wednesday, December 3, 2025 at 5:00 pm ETToronto, Ontario--(Newsfile Corp. - December 3, 2025) - Pineapple Financial Inc. (NYSE:PAPL) ("Pineapple" or the "Company"), a leading fintech platform, today announced audited financial results for the three and twelve month periods ended August 31, 2025.Full Year Fiscal 2025 Financial HighlightsGross Billings reached $17.4 million, up 7.1% from $16.3 million in the same period last yearRevenue rose 11.1% to $3.0 million, compared to $2.7 million in 2024Total Expenses declined 8.9% to $5.9 million, down from $6.5 million last yearL

    12/3/25 4:05:00 PM ET
    $PAPL
    Finance: Consumer Services
    Finance

    $CYAN
    $PAPL
    $RVP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Cyanotech Corporation

    SC 13D/A - CYANOTECH CORP (0000768408) (Subject)

    10/3/24 6:39:03 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13D/A filed by Cyanotech Corporation

    SC 13D/A - CYANOTECH CORP (0000768408) (Subject)

    9/12/24 12:25:52 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13D/A filed by Cyanotech Corporation

    SC 13D/A - CYANOTECH CORP (0000768408) (Subject)

    9/6/24 12:45:58 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care